Therdose Pharma Private Limited — Carmustine Exporter Profile
Indian Pharmaceutical Exporter · #4 for Carmustine · $455.2K export value · DGFT Verified
Therdose Pharma Private Limited is the #4 Indian exporter of Carmustine with $455.2K in export value and 22 verified shipments. Therdose Pharma Private Limited holds a 2.0% market share in Carmustine exports across 8 countries. The company exports 4 pharmaceutical products worth $1.1M across 2 therapeutic categories.
Therdose Pharma Private Limited — Carmustine Export Profile: Buyers & Destinations
Where Does Therdose Pharma Private Limited Export Carmustine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TAIWAN | $344.6K | 8 | 70.4% |
| CHILE | $117.8K | 8 | 24.1% |
| MALAYSIA | $17.2K | 3 | 3.5% |
| GEORGIA | $9.8K | 2 | 2.0% |
| COSTA RICA | $98 | 2 | 0.0% |
| SYRIA | $24 | 1 | 0.0% |
| KENYA | $11 | 1 | 0.0% |
| SAUDI ARABIA | $5 | 1 | 0.0% |
| GUATEMALA | $3 | 1 | 0.0% |
| MOROCCO | $0 | 1 | 0.0% |
Therdose Pharma Private Limited exports Carmustine to 10 countries. The largest destination is TAIWAN accounting for 70.4% of Therdose Pharma Private Limited's Carmustine shipments, followed by CHILE (24.1%) and MALAYSIA (3.5%). These destinations reflect Therdose Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Carmustine from Therdose Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DRAGON PHARMACEUTICALS CO LTD., | TAIWAN | $98.9K | 2 |
| DRAGON PHARMACEUTICAL CO LIMITED | TAIWAN | $98.9K | 2 |
| DRAGON PHARMACEUTICAL CO. LTD | TAIWAN | $98.6K | 2 |
| DRAGON PHARMACEUTICAL CO LTD | TAIWAN | $48.2K | 2 |
| LABORATORIOS KAMPAR S A., | CHILE | $40.4K | 2 |
| LABORATORIOS KAMPAR SA SAN SEBASTIAN | CHILE | $32.3K | 2 |
| LABORATORIOS KAMPAR SA | CHILE | $23.4K | 2 |
| FTA HEALTHCARE SDN BHD | MALAYSIA | $11.3K | 2 |
| LABORATORIOS KAMPAR S A.., | CHILE | $10.9K | 1 |
| LABORATORIES KAMPAR S A | CHILE | $10.8K | 1 |
Therdose Pharma Private Limited supplies Carmustine to 19 buyers globally. The largest buyer is DRAGON PHARMACEUTICALS CO LTD., (TAIWAN), followed by DRAGON PHARMACEUTICAL CO LIMITED (TAIWAN) and DRAGON PHARMACEUTICAL CO. LTD (TAIWAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Carmustine Export Value and How Much Does Therdose Pharma Private Limited Contribute?
India exported $6.5M worth of Carmustine through 340 shipments from 50 suppliers to 54 countries, serving 135 buyers globally. Therdose Pharma Private Limited contributes $455.2K to this total, accounting for 2.0% of India's Carmustine exports. Therdose Pharma Private Limited ships Carmustine to 10 countries through 19 buyers.
What Is the Average Shipment Value for Therdose Pharma Private Limited's Carmustine Exports?
Therdose Pharma Private Limited's average Carmustine shipment value is $20.7K per consignment, based on 22 shipments totaling $455.2K. The largest destination is TAIWAN (70.4% of Therdose Pharma Private Limited's Carmustine exports).
How Does Therdose Pharma Private Limited Compare to Other Indian Carmustine Exporters?
Therdose Pharma Private Limited ranks #4 among 50 Indian Carmustine exporters with a 2.0% market share. The top 3 exporters are EMCURE PHARMACEUTICALS LIMITED ($4.0M), MSN LABORATORIES PRIVATE LIMITED ($850.0K), INTAS PHARMACEUTICALS LIMITED ($778.2K). Therdose Pharma Private Limited processed 22 shipments to 8 destination countries.
What Carmustine Formulations Does Therdose Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CARMUSTINE FOR INJECTION USP 100 MG | $123.2K | 4 |
| CARMUSTINE FOR INJECTION USP 100 MG(CARMUTHER 100) | $111.3K | 3 |
| CARMUSTINE FOR INJECTION USP 100 MG (CARMUTHER 100) | $71.3K | 4 |
| CARMUSTINE FOR INJECTION USP 100 MG (CARMUTHER 100)VLS | $69.0K | 2 |
| CARMUSTINE FOR INJECTION USP 100 MG CARMUTHER 100 QTY 401 VIALS | $48.2K | 1 |
| CARMUSTINE FOR INJECTION USP 100 MG CARMUTHER 100 | $30.0K | 3 |
| CARMUSTINE FOR INJECTION USP 100 MGCARMUTHER 100 | $20.9K | 1 |
| CARMUSTINE FOR INJECTION USP 100MG | $7.5K | 1 |
| Carmustine for Injection USP 100mg (CARMUTHER 100) | $6.0K | 1 |
| CARMUSTINE FOR INJECTION USP 100 MGCNU | $2.0K | 1 |
Therdose Pharma Private Limited exports 15 distinct Carmustine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CARMUSTINE FOR INJECTION USP 100 MG with 4 shipments worth $123.2K.
How Does Therdose Pharma Private Limited Compare to Nearest Carmustine Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MSN LABORATORIES PRIVATE LIMITED | $850.0K | 17 | 4 | $50.0K |
| 3 | INTAS PHARMACEUTICALS LIMITED | $778.2K | 44 | 6 | $17.7K |
| 4 | THERDOSE PHARMA PRIVATE LIMITED ★ | $455.2K | 22 | 8 | $20.7K |
| 5 | SP ACCURE LABS PRIVATE LIMITED | $229.6K | 23 | 7 | $10.0K |
| 6 | EMCURE PHARMACEUTICALS LTD | $56.8K | 3 | 3 | $18.9K |
Therdose Pharma Private Limited ranks #4 among 50 Indian Carmustine exporters. Average shipment value of $20.7K compared to the market average of $129.7K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Carmustine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 67 | 19.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 45 | 13.2% |
| HYDERABAD AIR | 38 | 11.2% |
| HYDERABAD ACC (INHYD4) | 28 | 8.2% |
| AHEMDABAD AIR ACC (INAMD4) | 23 | 6.8% |
| Bombay Air | 18 | 5.3% |
| DELHI AIR | 15 | 4.4% |
| AHEMDABAD AIR | 11 | 3.2% |
What Other Advanced Oncology Products Does Therdose Pharma Private Limited Export?
Therdose Pharma Private Limited also exports these advanced oncology products. Each links to the detailed product page.
About Therdose Pharma Private Limited
Therdose Pharma Private Limited exports 4 products worth $1.1M. Beyond Carmustine, top products include Docetaxel, Irinotecan, Pazopanib. View the complete Therdose Pharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Carmustine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Carmustine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Therdose Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 28 individual customs records matching Therdose Pharma Private Limited exporting Carmustine, covering 15 formulations to 10 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 54+ countries, 135+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Carmustine Export Data from Therdose Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Therdose Pharma Private Limited's Carmustine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Therdose Pharma Private Limited
Full Company Profile →
4 products · $1.1M total trade · 2 categories
Carmustine Stats
Company Overview
Top Products by Therdose Pharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Therdose Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Carmustine. For current shipment-level data, contact TransData Nexus.